Samara Rahman, 74, enrolled in a clinical trial at UCLA Health that was evaluating an “off-the-shelf” vaccine that is given after surgery to prevent or delay the cancer from coming back in high-risk patients.
Folasade May, MD, PhD, UCLA Health cancer prevention researcher and gastroenterologist, is available for interview on a variety of topics during colorectal cancer awareness month.
A UCLA Health-led study found a combination of interventions of one-on-one telehealth coaching, peer support forums, and automated text messages more than doubled the use of the HIV prevention strategy, called PrEP, among younger, at-risk Americans, a group that historically has had low use of the medication.
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma.
A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil has been approved by the FDA for the first-line treatment of metastatic pancreatic adenocarcinoma.
UCLA Therapy dogs dressed in costumes deliver Valentines to pediatric patients on the unit.
A new study, co-led by UCLA Health and the University of Glasgow, found that young teenagers who develop a strong distrust of other people as a result of childhood bullying are substantially more likely to have significant mental health problems as they enter adulthood compared to those who do not develop interpersonal trust issues.
Therapy dogs dressed in costumes deliver Valentines to pediatric patients on the unit.
The UCLA team played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate (ADC), mirvetuximab soravtansine, for the treatment of platinum-resistant ovarian cancer.
Genicular artery embolization is a non-invasive alternative to knee replacement.
New prostate screening guidelines organized by the Prostate Cancer Foundation aim to address the longstanding health disparity in prostate cancer: Black men are diagnosed with and die from prostate cancer at a much higher rate than white men.
A UCLA Health-led evaluation of Los Angeles County’s pilot program aimed at bolstering aid to gravely disabled homeless residents found the initiative could offer a promising framework to improve housing and health outcomes for this vulnerable population while also relieving overburdened psychiatric hospitals.
Black, indigenous, and people of color (BIPOC) who were infected with COVID-19 experienced greater negative aftereffects in health and work loss than did similarly infected white participants, new research finds.
A new study led by researchers at UCLA may change the way clinicians and scientists understand, diagnose and treat placenta accreta spectrum disorder, a serious condition in which the placenta fails to separate from the uterus at birth, jeopardizing the life and health of both mother and baby.
UCLA-led research shows targeting the protein UCHL1 could lead to a new therapeutic approach for managing these cancers
Surgeons and scientists at UCLA Health will present data on the latest basic science, translational and health services research that has the potential to improve patient care at the 19th annual Academic Surgical (ASC) Congress in Washington, D.C., Feb. 6 to 8.
Infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants. In-utero exposure increased their risk of the disorder that most often strikes premature infants.
You may have heard about the gut microbiome and its influence on a person’s overall health and well-being.
UCLA Health has appointed leading breast surgical oncologist Dr. Mediget Teshome as the new chief of breast surgery and director of breast health.
A team of researchers from UCLA and UC Irvine have created a unique repository of electronic health record data and high-fidelity physiological waveform data from tens of thousands of surgeries that will integrate artificial intelligence to improve patient outcomes.
A new study sheds light on how autophagy, the body’s process for removing damaged cell parts, when impaired, can play a role in causing heart failure
A new study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center shows that using high doses of radiation while integrating an ablative radiotherapy technique called stereotactic ablative radiotherapy (SABR) concurrently with chemotherapy is safe and effective in treating people with locally advanced non-small cell lung cancer that is not suitable for surgery.
Scooter injuries nearly tripled across the U.S. from 2016 to 2020, with a concurrent increase in severe injuries requiring orthopedic and plastic surgery over the same period.
Embargoed research finds an average of 22 adolescents 14 to 18 years of age died in the U.S. each week in 2022 from drug overdoses, raising the death rate for this group to 5.2 per 100,000-- driven by fentanyl in counterfeit pills. The researchers also found 19 "hotspot" counties with particularly high overdose deaths.
Differences in blood flow in the retina could explain why some migraine patients experience visual symptoms while others do not, according to UCLA study.
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have received a five-year, $3 million grant from the National Cancer Institute to identify novel cancer biomarkers and develop AI that can detect and predict aggressive prostate cancer to help avoid unnecessary treatments and their associated negative side effects.
A new report by a UCLA neurologist and collaborators draws upon patient voices and lived experiences to identify the common pitfalls of Parkinson’s diagnoses and create a guidebook for how medical providers – from seasoned specialists to rural community physicians – can avoid them.
Infertility remains a widespread issue impacting many people seeking to create families.
UCLA Health dementia care specialists say caregiving and holiday festivities do not have to be mutually exclusive, but do require some adaptations to make the season enjoyable for all.
The high-fat, low-carbohydrate ketogenic diet is more than just a trendy weight-loss tactic. It has also been known to help control seizures in children with epilepsy, particularly those who don’t respond to first-line anti-seizure medications.
Dr. Aditya Bardia, a renowned breast medical oncologist and physician scientist who specializes in developing novel targeted and personalized therapies, has joined the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center where he will assume several leadership roles across the institution.
The Periodic Assessment of Trajectories of Housing, Health and Homelessness Study (PATHS) — a joint research initiative between the USC Dworak-Peck School of Social Work and UCLA Fielding School of Public Health, focusing on the lives and experiences of people experiencing homelessness (PEH) in LA County — features a representative sample of PEH who were unsheltered, with ongoing monthly survey tracking on housing, health, and well-being even if respondents move into housing or shelter.
A new UCLA Health study is shedding light on how using hormonal contraceptive pills may affect women’s responses to stress and their risk for inflammation-related illnesses.
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have received two grants totaling $9.1 million from the National Cancer Institute to advance liquid biopsy technologies for the early detection of cancer, which can significantly improve treatment outcomes and reduce the number of deaths caused by the disease.
Two new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way prostate tumors survive and grow — advancements that can help explain why some prostate cancers become resistant to hormone therapy, the most commonly used treatment for men with advanced stages of the disease.
About 20% of patients whose medical records showed them as being alive were in fact deceased according to California data.
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.
A nearly decade-long study by UCLA researchers found that substance abuse treatment of any kind may help to reduce methamphetamine usage among men who have sex with other men.
call for expanded reporting of medical care given in ICE detention centers
Dr. Bryan Burt, an internationally recognized surgeon-scientist and surgical oncologist, has joined UCLA Health and the David Geffen School of Medicine at UCLA as the new chief of thoracic surgery and professor of surgery.
Researchers at the UCLA Jonsson Comprehensive Cancer Center have found certain immune cells can still fight cancer even when the cancer cells lack an important protein that the immune system relies on to help track down cancer cells.
Q&A about menopause
New research finds female surgeons had slightly lower patient mortality than males for elective surgeries, but no gender difference for non-elective procedures.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
